# ctDNA as a Biomarker for Treatment Response in HNSCC

> **NCT03540563** · NA · COMPLETED · sponsor: **The Netherlands Cancer Institute** · enrollment: 70 (actual)

## Conditions studied

- Carcinoma, Squamous Cell of Head and Neck

## Interventions

- **OTHER:** Blood draw

## Key facts

- **NCT ID:** NCT03540563
- **Lead sponsor:** The Netherlands Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-07-16
- **Primary completion:** 2023-08-01
- **Final completion:** 2023-08-01
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2024-02-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03540563

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03540563, "ctDNA as a Biomarker for Treatment Response in HNSCC". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03540563. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*